rethinkTHC Search
Menu
Study breakdown

Could the Endocannabinoid System Influence Your Dreams?

ReviewPreliminary evidence
The takeaway

The endocannabinoid system modulates consciousness, emotions, and sleep, leading researchers to hypothesize it also influences dream content, with preliminary evidence that cannabinoids reduce PTSD-related nightmares.

Read this if you have noticed changes in your dreams with cannabis use or are interested in how the endocannabinoid system relates to dreaming and nightmares.

Preliminary evidence shows cannabinoids can reduce PTSD nightmares

What the researchers found

This review proposed a novel hypothesis: that the endocannabinoid system influences dream activity.

The reasoning builds on established evidence that the endocannabinoid system modulates multiple processes integral to dreaming: consciousness, learning and memory, attention, pain perception, emotions, and the sleep-wake cycle itself. Blocking CB1 receptors or inhibiting FAAH activity affects wakefulness, while blocking anandamide transport enhances sleep.

Preliminary clinical evidence supports the hypothesis. Treatment with cannabinoids has been reported to decrease PTSD symptoms, including nightmares, suggesting direct modulation of dream content.

The review proposed a conceptual framework for understanding how the endocannabinoid system might influence the generation of dream experiences, integrating evidence from human and animal models on emotional states, sleep architecture, and consciousness.

Why it matters

If the endocannabinoid system modulates dream content, it could explain why cannabis users often report reduced dreaming and why PTSD patients sometimes find relief from nightmares with cannabinoids. Understanding this connection could lead to targeted treatments for trauma-related sleep disturbances.

The numbers in context

The review cites preliminary PTSD studies showing cannabinoid-related nightmare reduction but does not report specific pooled statistics.

How the study worked

Literature review of PubMed sources examining the endocannabinoid system's role in consciousness, emotions, sleep, and dream activity. Proposes a conceptual framework linking these functions.

What this study cannot tell us

The dream modulation hypothesis is largely theoretical and has not been directly tested. The mechanisms linking endocannabinoid signaling to dream content remain speculative. PTSD nightmare reduction could work through anxiety reduction rather than direct dream modulation.

How to read the evidence

Hypothesis-generating review based on indirect evidence. Preliminary because the central hypothesis about dream modulation has not been directly tested.

When this study was published

Published in 2017.

The bigger picture

Dreams, particularly nightmares, are among the most distressing symptoms of PTSD and contribute to sleep avoidance and insomnia. An endocannabinoid mechanism for dream modulation could provide a biological basis for developing cannabinoid-based treatments for trauma-related sleep disorders.

Questions still open

  • Does chronic cannabis use suppress REM sleep and dreaming through endocannabinoid mechanisms? Would cannabis withdrawal produce more vivid dreams by releasing endocannabinoid suppression? Could targeted endocannabinoid modulation reduce nightmares without suppressing all dreaming?

Common questions

Does cannabis affect dreaming?
Many cannabis users report reduced dreaming, and this review proposes the endocannabinoid system directly modulates dream content. Preliminary evidence shows cannabinoids can reduce PTSD-related nightmares, though the exact mechanisms remain unclear.
Could cannabis help with nightmares?
Preliminary clinical evidence suggests cannabinoids can reduce PTSD-related nightmares. This review proposes this works through the endocannabinoid system's influence on dreaming, but the hypothesis requires further testing.

Read the original research

The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.

CNS & neurological disorders drug targets, 16(4), 370-379

Citation

Murillo-Rodriguez, Eric; Pastrana-Trejo, Jose Carlos; Salas-Crisóstomo, Mireille; de-la-Cruz, Miriel. (2017). The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.. CNS & neurological disorders drug targets, 16(4), 370-379. https://doi.org/10.2174/1871527316666170223161908

Explore the wider topic